ESR1 and neoplasm: In the early stages of bone metastasis, estrogen receptor (ER)-positive luminal cancers release signal peptide, CUB domain and EGF-like domain containing 2 (SCUBE2), which may help to induce osteoblasts to differentiate into osteoclasts, thereby inhibiting NK cells activity and providing favorable conditions for tumor colonization (57).